Annexin A1 as a Regulator of Immune Response in Cancer

Annexin A1 is a 37 kDa phospholipid-binding protein that is expressed in many tissues and cell types, including leukocytes, lymphocytes and epithelial cells. Although Annexin A1 has been extensively studied for its anti-inflammatory activity, it has been shown that, in the cancer context, its activi...

Full description

Bibliographic Details
Main Authors: Thaise Gonçalves Araújo, Sara Teixeira Soares Mota, Helen Soares Valença Ferreira, Matheus Alves Ribeiro, Luiz Ricardo Goulart, Lara Vecchi
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/9/2245
_version_ 1829453060833804288
author Thaise Gonçalves Araújo
Sara Teixeira Soares Mota
Helen Soares Valença Ferreira
Matheus Alves Ribeiro
Luiz Ricardo Goulart
Lara Vecchi
author_facet Thaise Gonçalves Araújo
Sara Teixeira Soares Mota
Helen Soares Valença Ferreira
Matheus Alves Ribeiro
Luiz Ricardo Goulart
Lara Vecchi
author_sort Thaise Gonçalves Araújo
collection DOAJ
description Annexin A1 is a 37 kDa phospholipid-binding protein that is expressed in many tissues and cell types, including leukocytes, lymphocytes and epithelial cells. Although Annexin A1 has been extensively studied for its anti-inflammatory activity, it has been shown that, in the cancer context, its activity switches from anti-inflammatory to pro-inflammatory. Remarkably, Annexin A1 shows pro-invasive and pro-tumoral properties in several cancers either by eliciting autocrine signaling in cancer cells or by inducing a favorable tumor microenvironment. Indeed, the signaling of the <i>N</i>-terminal peptide of AnxA1 has been described to promote the switching of macrophages to the pro-tumoral M2 phenotype. Moreover, AnxA1 has been described to prevent the induction of antigen-specific cytotoxic T cell response and to play an essential role in the induction of regulatory T lymphocytes. In this way, Annexin A1 inhibits the anti-tumor immunity and supports the formation of an immunosuppressed tumor microenvironment that promotes tumor growth and metastasis. For these reasons, in this review we aim to describe the role of Annexin A1 in the establishment of the tumor microenvironment, focusing on the immunosuppressive and immunomodulatory activities of Annexin A1 and on its interaction with the epidermal growth factor receptor.
first_indexed 2024-03-10T07:49:27Z
format Article
id doaj.art-86301f41f936439581010cbbb51f2cc4
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T07:49:27Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-86301f41f936439581010cbbb51f2cc42023-11-22T12:23:06ZengMDPI AGCells2073-44092021-08-01109224510.3390/cells10092245Annexin A1 as a Regulator of Immune Response in CancerThaise Gonçalves Araújo0Sara Teixeira Soares Mota1Helen Soares Valença Ferreira2Matheus Alves Ribeiro3Luiz Ricardo Goulart4Lara Vecchi5Laboratory of Genetics and Biotechnology, Federal University of Uberlandia, Patos de Minas 387400-128, MG, BrazilLaboratory of Genetics and Biotechnology, Federal University of Uberlandia, Patos de Minas 387400-128, MG, BrazilLaboratory of Genetics and Biotechnology, Federal University of Uberlandia, Patos de Minas 387400-128, MG, BrazilLaboratory of Genetics and Biotechnology, Federal University of Uberlandia, Patos de Minas 387400-128, MG, BrazilLaboratory of Nanobiotechnology, Federal University of Uberlandia, Uberlandia 38400-902, MG, BrazilLaboratory of Nanobiotechnology, Federal University of Uberlandia, Uberlandia 38400-902, MG, BrazilAnnexin A1 is a 37 kDa phospholipid-binding protein that is expressed in many tissues and cell types, including leukocytes, lymphocytes and epithelial cells. Although Annexin A1 has been extensively studied for its anti-inflammatory activity, it has been shown that, in the cancer context, its activity switches from anti-inflammatory to pro-inflammatory. Remarkably, Annexin A1 shows pro-invasive and pro-tumoral properties in several cancers either by eliciting autocrine signaling in cancer cells or by inducing a favorable tumor microenvironment. Indeed, the signaling of the <i>N</i>-terminal peptide of AnxA1 has been described to promote the switching of macrophages to the pro-tumoral M2 phenotype. Moreover, AnxA1 has been described to prevent the induction of antigen-specific cytotoxic T cell response and to play an essential role in the induction of regulatory T lymphocytes. In this way, Annexin A1 inhibits the anti-tumor immunity and supports the formation of an immunosuppressed tumor microenvironment that promotes tumor growth and metastasis. For these reasons, in this review we aim to describe the role of Annexin A1 in the establishment of the tumor microenvironment, focusing on the immunosuppressive and immunomodulatory activities of Annexin A1 and on its interaction with the epidermal growth factor receptor.https://www.mdpi.com/2073-4409/10/9/2245Annexin A1tumor microenvironmentimmune-suppressioncancer aggressiveness
spellingShingle Thaise Gonçalves Araújo
Sara Teixeira Soares Mota
Helen Soares Valença Ferreira
Matheus Alves Ribeiro
Luiz Ricardo Goulart
Lara Vecchi
Annexin A1 as a Regulator of Immune Response in Cancer
Cells
Annexin A1
tumor microenvironment
immune-suppression
cancer aggressiveness
title Annexin A1 as a Regulator of Immune Response in Cancer
title_full Annexin A1 as a Regulator of Immune Response in Cancer
title_fullStr Annexin A1 as a Regulator of Immune Response in Cancer
title_full_unstemmed Annexin A1 as a Regulator of Immune Response in Cancer
title_short Annexin A1 as a Regulator of Immune Response in Cancer
title_sort annexin a1 as a regulator of immune response in cancer
topic Annexin A1
tumor microenvironment
immune-suppression
cancer aggressiveness
url https://www.mdpi.com/2073-4409/10/9/2245
work_keys_str_mv AT thaisegoncalvesaraujo annexina1asaregulatorofimmuneresponseincancer
AT sarateixeirasoaresmota annexina1asaregulatorofimmuneresponseincancer
AT helensoaresvalencaferreira annexina1asaregulatorofimmuneresponseincancer
AT matheusalvesribeiro annexina1asaregulatorofimmuneresponseincancer
AT luizricardogoulart annexina1asaregulatorofimmuneresponseincancer
AT laravecchi annexina1asaregulatorofimmuneresponseincancer